Bolt Biotherapeutics, Inc.
BOLT
$3.68
-$0.18-4.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.82% | 34.38% | 58.39% | 52.93% | 59.61% |
| Total Depreciation and Amortization | -50.72% | -49.12% | -40.14% | -34.09% | -24.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.45% | 37.24% | -32.73% | -32.27% | -61.76% |
| Change in Net Operating Assets | 76.36% | 40.38% | -93.23% | -555.88% | -238.78% |
| Cash from Operations | 31.85% | 39.97% | 50.41% | 30.32% | 40.55% |
| Capital Expenditure | -- | -- | -- | -75.61% | -- |
| Sale of Property, Plant, and Equipment | -- | -96.78% | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.23% | -41.92% | -91.22% | 5.43% | -40.05% |
| Cash from Investing | -27.99% | -45.55% | -91.22% | 4.35% | -40.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 35.71% | -- | -82.76% | -- | -82.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 35.71% | -- | -82.76% | -- | -82.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.39% | -107.93% | -180.18% | 157.00% | -37.63% |